Research Article

Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis

Table 1

Binding parameters of selected small drug molecules with TGF-β1.

S. No.Small drug moleculesTarget proteinBinding affinity (kcal/mol)Inhibition constant, (nM)

1SilmitasertibTGF-β1-9.31.61889E-06
2SR10067-7.81.91655E-06
3Neoruscogenin-7.53.17997E-06
4SR1078-7.34.45681E-06
5SRT2183-7.34.45681E-06